Published in Arch Dermatol Res on January 01, 1988
Ia antigen expression on human epidermal Langerhans cells. Nature (1977) 4.05
Immunologic properties of purified epidermal Langerhans cells. Distinct requirements for stimulation of unprimed and sensitized T lymphocytes. J Exp Med (1986) 3.74
Antigen presentation: comments on its regulation and mechanism. J Immunol (1984) 3.68
Immunohistological analysis of delayed-type hypersensitivity in man. Cell Immunol (1982) 2.86
Epidermal cell (keratinocyte)-derived thymocyte-activating factor (ETAF). J Immunol (1981) 2.74
Immune cell populations in cutaneous delayed-type hypersensitivity. J Exp Med (1983) 2.33
Influence of delayed immune reactions on human epidermal keratinocytes. Proc Natl Acad Sci U S A (1986) 2.11
Studies on human epidermal Langerhans cells. I. Allo-activating and antigen-presenting capacity. Scand J Immunol (1980) 2.09
Identification of C5ades arg and an anionic neutrophil-activating peptide (ANAP) in psoriatic scales. J Invest Dermatol (1986) 1.96
Apposition of mononuclear cells to langerhans cells in contact allergic reactions. An ultrastructural study. Acta Derm Venereol (1973) 1.95
The role of Langerhans cells in allergic contact hypersensitivity. A review of findings in man and guinea pigs. J Invest Dermatol (1976) 1.93
Analogous functions of macrophages and Langerhans cells in the initiation in the immune response. J Invest Dermatol (1978) 1.71
Interleukin 1 is present in normal human epidermis. J Immunol (1986) 1.70
Expression of HLA-DR (Ia like) antigen on epidermal keratinocytes in human dermatoses. Clin Exp Immunol (1984) 1.54
Human keratinocytes express HLA-DR antigens in the tuberculin reaction. Scand J Immunol (1984) 1.15
Characteristics of an epidermal cell thymocyte-activating factor (ETAF) produced by human epidermal cells and a human squamous cell carcinoma cell line. J Invest Dermatol (1983) 1.12
Epidermis and lymphocyte interactions during a tuberculin skin reaction. II. Epidermis contains specific lymphocyte chemotactic factors. J Invest Dermatol (1986) 1.12
Normal epidermis contains high amounts of natural tissue IL 1 biochemical analysis by HPLC identifies a MW approximately 17 Kd form with a P1 5.7 and a MW approximately 30 Kd form. Lymphokine Res (1986) 1.09
In vitro mixed skin cell lymphocyte culture reaction (MSLR) in man: analysis of the epidermal cell and T cell subpopulations. Clin Exp Immunol (1982) 0.96
Interleukin-1-like activity in horny layer extracts: decreased activity in scale extracts of psoriasis and sterile pustular dermatoses. Dermatologica (1986) 0.93
Effect of depletion of epidermal dendritic cells on the induction of contact sensitivity in the guinea-pig. Br J Dermatol (1985) 0.85
Formation of epidermal cell thymocyte-activating factor (ETAF) from cultured human keratinocytes from normal and uninvolved psoriatic skin. J Invest Dermatol (1987) 0.81
Presence of chemotactic peptides other than C5a anaphylatoxin in scales of psoriasis and sterile pustular dermatoses. Acta Derm Venereol (1986) 0.78
Update on the use of ciclosporin in immune-mediated dermatoses. Br J Dermatol (2006) 2.49
A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med (1997) 2.29
Psoriasin: a novel chemotactic protein. J Invest Dermatol (1996) 1.59
Atopic dermatitis and birth factors: historical follow up by record linkage. BMJ (1997) 1.48
Temporary suppression of lymphocyte transformation after tuberculin skin testing. Immunology (1974) 1.46
The dermatoscopic ABCD rule does not improve diagnostic accuracy of malignant melanoma. Acta Derm Venereol (1999) 1.40
Monocyte and neutrophil chemotaxis in psoriasis. Relation to the clinical status and the type of psoriasis. J Am Acad Dermatol (1986) 1.38
Reactivity of lymphocytes from patients with syphilis towards T. pallidum antigen in the leucocyte migration and lymphocyte transformation tests. Br J Vener Dis (1976) 1.31
Human IL-10 is a chemoattractant for CD8+ T lymphocytes and an inhibitor of IL-8-induced CD4+ T lymphocyte migration. J Immunol (1993) 1.31
Establishment of two continuous T-cell strains from a single plaque of a patient with mycosis fungoides. In Vitro Cell Dev Biol (1992) 1.31
Lymphocyte transformation test with liver-specific protein and phytohaemagglutinin in patients with liver disease. Clin Exp Immunol (1976) 1.28
Construction and validation of a photographic guide for assessing severity of chronic hand dermatitis. Br J Dermatol (2005) 1.24
A continuous T-cell line from a patient with Sézary syndrome. Arch Dermatol Res (1987) 1.23
The delayed-type hypersensitivity reaction is dependent on IL-8. Inhibition of a tuberculin skin reaction by an anti-IL-8 monoclonal antibody. J Immunol (1995) 1.20
Epidermis and lymphocyte interactions during a tuberculin skin reaction. II. Epidermis contains specific lymphocyte chemotactic factors. J Invest Dermatol (1986) 1.12
The immunological profile of mycosis fungoides. Clin Exp Immunol (1982) 1.09
Modulation of natural killer cell activity in patients with atopic dermatitis. J Invest Dermatol (1984) 1.09
PPD and mitogen responsiveness of lymphocytes from patients with atopic dermatitis. Clin Exp Immunol (1977) 1.08
Frequency of skeletal disease, arthro-osteitis, in patients with pustulosis palmoplantaris. J Am Acad Dermatol (1988) 1.08
IL-8 induces T cell chemotaxis, suppresses IL-4, and up-regulates IL-8 production by CD4+ T cells. J Leukoc Biol (1996) 1.06
Epidermis and lymphocyte interactions during an allergic patch test reaction. Increased activity of ETAF/IL-1, epidermal derived lymphocyte chemotactic factor and mixed skin lymphocyte reactivity in persons with type IV allergy. J Invest Dermatol (1988) 1.03
SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis. Br J Dermatol (2001) 1.03
Recombinant human growth-regulated oncogene-alpha induces T lymphocyte chemotaxis. A process regulated via IL-8 receptors by IFN-gamma, TNF-alpha, IL-4, IL-10, and IL-13. J Immunol (1995) 1.01
A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris. Acta Derm Venereol (2002) 1.01
Suppression of tuberculin skin reactivity by prior tuberculin skin testing. Immunology (1975) 1.01
Cytogenetic findings in cell lines from cutaneous T-cell lymphoma. Dermatol Clin (1994) 1.00
Quantitative determination of IL-1 alpha-induced IL-8 mRNA levels in cultured human keratinocytes, dermal fibroblasts, endothelial cells, and monocytes. J Invest Dermatol (1991) 0.99
Mast cells and atopic dermatitis. Stereological quantification of mast cells in atopic dermatitis and normal human skin. Arch Dermatol Res (1997) 0.99
Regulation of human T lymphocyte chemotaxis in vitro by T cell-derived cytokines IL-2, IFN-gamma, IL-4, IL-10, and IL-13. J Immunol (1995) 0.99
Expression and secretion of leukocyte chemotactic cytokines by normal human melanocytes and melanoma cells. J Invest Dermatol (1991) 0.99
A study of the safety and efficacy of calcipotriol and betamethasone dipropionate scalp formulation in the long-term management of scalp psoriasis. Dermatology (2008) 0.96
Quantification of the 3H-ouabain binding site concentration in human myocardium: a postmortem study. Cardiovasc Res (1986) 0.96
Studies on the role of the thymus and T cells in the in vivo suppression of delayed hypersensitivity (desensitization): radiosensitivity of the mechanism inducing nonspecific anergy. J Immunol (1977) 0.96
Paraneoplastic skin manifestations of lung cancer. Acta Derm Venereol (2000) 0.96
Identification of functional domains on human interleukin 10. Proc Natl Acad Sci U S A (1997) 0.94
Clinical patch test data evaluated by multivariate analysis. Danish Contact Dermatitis Group. Contact Dermatitis (1989) 0.92
Establishment of T and B cell lines from patients with mycosis fungoides. Br J Dermatol (1984) 0.91
Peptide-induced anergy in allergen-specific human Th2 cells results in lack of cytokine production and B cell help for IgE synthesis. Reversal by IL-2, not by IL-4 or IL-13. J Immunol (1995) 0.90
Cutaneous immunological activation elicited by a low-fluence pulsed dye laser. Br J Dermatol (2005) 0.89
Patch test reactivity to nickel alloys. Contact Dermatitis (1987) 0.89
Eotaxin activates T cells to chemotaxis and adhesion only if induced to express CCR3 by IL-2 together with IL-4. J Immunol (1999) 0.89
Epidermal lymphocyte chemotactic factor specifically attracts OKT4-positive lymphocytes. Arch Dermatol Res (1988) 0.89
CD4+ CD8+ (thymocyte-like) T lymphocytes present in blood and skin from patients with atopic dermatitis suggest immune dysregulation. Br J Dermatol (2001) 0.88
Chronic recurrent multifocal osteomyelitis: a follow-up study. J Pediatr Orthop (1988) 0.88
Clinical and dermatoscopic diagnosis of malignant melanoma. Assessed by expert and non-expert groups. Acta Derm Venereol (1999) 0.88
Recombinant human interleukin-8 is a potent activator of canine neutrophil aggregation, migration, and leukotriene B4 biosynthesis. J Invest Dermatol (1991) 0.88
Natural killer cell activity in syphilis. Arch Dermatol Res (1982) 0.88
Temperature optimum and rabbit blood cell culture. Acta Pathol Microbiol Scand B Microbiol Immunol (1972) 0.87
Toxic epidermal necrolysis and erythema multiforme following therapy with terbinafine. Acta Derm Venereol (1994) 0.87
Leukocyte extravasation as a target for anti-inflammatory therapy - Which molecule to choose? Exp Dermatol (2005) 0.87
Depression of natural killer cell activity by syphilitic serum and immune complexes. Br J Vener Dis (1982) 0.87
Association between atopic dermatitis and insulin-dependent diabetes mellitus: a case-control study. Lancet (2001) 0.86
Chemotaxis of human osteoblasts. Effects of osteotropic growth factors. APMIS (1995) 0.86
Common clonal chromosome aberrations in cytokine-dependent continuous human T-lymphocyte cell lines. Cancer Genet Cytogenet (1995) 0.86
In vitro parameters of cell-mediated immune reactions in healthy individuals following immune-stimulation attempts with levamisole. Acta Allergol (1975) 0.86
Consensus statement on the safety profile of topical calcineurin inhibitors. Dermatology (2005) 0.86
The efficacy of a moisturizer (Locobase) among cleaners and kitchen assistants during everyday exposure to water and detergents. Contact Dermatitis (1993) 0.85
Expression of IL-18 mRNA and secretion of IL-18 are reduced in monocytes from patients with atopic dermatitis. J Allergy Clin Immunol (2001) 0.85
Ciclosporin A in acrodermatitis continua. Dermatologica (1987) 0.85
Subpopulations of T lymphocytes and non-specific suppressor cell activity in patients with atopic dermatitis. Clin Exp Immunol (1981) 0.84
Preparation of human epidermal tissue for functional immune studies. Acta Derm Venereol (1988) 0.84
Use of the polymerase chain reaction in quantification of interleukin 8 mRNA in minute epidermal samples. J Invest Dermatol (1992) 0.84
Reversal of human allergic T helper 2 responses by engagement of signaling lymphocytic activation molecule. J Immunol (1997) 0.84
Telomerase activity is increased and telomere length shortened in T cells from blood of patients with atopic dermatitis and psoriasis. J Immunol (2000) 0.84
Skin irritancy from fish is related to its postmortem age. Contact Dermatitis (1989) 0.84
Chemotaxis and IL-8 receptor expression in B cells from normal and HIV-infected subjects. J Immunol (1997) 0.84
Lysophosphatidylcholine: a chemoattractant to human T lymphocytes. Arch Dermatol Res (1994) 0.83
Cetirizine inhibits the in vitro and ex vivo chemotactic response of T lymphocytes and monocytes. J Allergy Clin Immunol (1995) 0.83
Fatal toxic epidermal necrolysis associated with ceftazidine and vancomycin therapy: a report of two cases. Acta Derm Venereol (2001) 0.82
Dermatoscopic prediction of melanoma thickness using latent trait analysis and likelihood ratios. Acta Derm Venereol (2001) 0.82
Cytokine expression of skin T-lymphocytes from patients with atopic dermatitis. Acta Derm Venereol (2001) 0.82
1,25(OH)2-D3 is a potent regulator of interleukin-1 induced interleukin-8 expression and production. Biochem Biophys Res Commun (1991) 0.81
The relevance of low skin temperature inhibiting histamine-induced itch to the location of contact urticarial symptoms in the fish processing industry. Contact Dermatitis (1989) 0.81
The role of topical calcineurin inhibitors in atopic dermatitis. Br J Dermatol (2004) 0.81
Transfer factor applied to intensify the cell-mediated immunological reactions against Mycobacterium avium. Acta Allergol (1974) 0.81
Methotrexate inhibits the human C5a-induced skin response in patients with psoriasis. J Invest Dermatol (1987) 0.81
Interleukin 13 suppresses cytokine production and stimulates the production of 15-HETE in PBMC. A comparison between IL-4 and IL-13. Cytokine (1995) 0.81
Treatment of head and neck dermatitis comparing itraconazole 200 mg and 400 mg daily for 1 week with placebo. J Eur Acad Dermatol Venereol (2004) 0.81
Interleukin-8 induces its own production in CD4+ T lymphocytes: a process regulated by interleukin 10. Biochem Biophys Res Commun (1995) 0.81
Defective monocyte and polymorphonuclear leukocyte chemotaxis and clinical characteristics in atopic dermatitis. Arch Dermatol Res (1986) 0.81
Psoriatic arthritis mutilans (PAM) in the Nordic countries: demographics and disease status. The Nordic PAM study. Scand J Rheumatol (2013) 0.80
C-type particles are inducible in Se-Ax, a continuous T-cell line from a patient with Sézary's syndrome. Arch Dermatol Res (1988) 0.80
Long-term, intermittent treatment of chronic hand eczema with mometasone furoate. Br J Dermatol (1999) 0.80
Basophil histamine release induced by anti-IgE and concanavalin A. Relation to the total plasma IgE content. Allergy (1993) 0.80
Sweat pore density on the fingertips of atopic patients. Br J Dermatol (1987) 0.80
Interaction of warfarin with human serum albumin. A stoichiometric description. Mol Pharmacol (1985) 0.79
Purified Der p1 and p2 patch tests in patients with atopic dermatitis: evidence for both allergenicity and proteolytic irritancy. Acta Derm Venereol (1998) 0.79
Modulating effects of enzymes on T gamma and T mu cells in patients with atopic dermatitis. J Invest Dermatol (1983) 0.79
Transfer factor in mycosis fungoides: three years experience. Dermatologica (1980) 0.79
Human monocyte and polymorphonuclear leukocyte chemotactic and chemokinetic responses to leukotriene B4 and FMLP. Acta Pathol Microbiol Immunol Scand C (1987) 0.79
IL-4 and IL-13, but not IL-10, are chemotactic factors for human osteoblasts. Cytokine (1995) 0.79
In vivo and in vitro changes in cell-mediated immunity following tuberculin skin testing in humans. Br J Dermatol (1985) 0.79
Serum albumin--a non-saturable carrier. Acta Pharmacol Toxicol (Copenh) (1984) 0.79